Phenol

Phenol

SCHEMBL9302707

CC(C)N.Oc1ccccc1

nearest known ligand 0.65

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA12 O43570 1/20 0.65
CA1 P00915 1/20 0.65
CA2 P00918 1/20 0.65
GLA P06280 1/20 0.65
CA3 P07451 1/20 0.65
CA4 P22748 1/20 0.65
CA9 Q16790 1/20 0.65
TDP1 Q9NUW8 1/20 0.65
CA14 Q9ULX7 1/20 0.65
ADRA2A P08913 1/20 0.48
ADRA2C P18825 1/20 0.48
LMNA P02545 1/20 0.48
HIF1A Q16665 1/20 0.48
KDM4E B2RXH2 1/20 0.48
TAAR1 Q96RJ0 5/20 0.46
SLC6A2 P23975 3/20 0.46
ALDH1A1 P00352 1/20 0.46
MMP3 P08254 1/20 0.46
BCL2L1 Q07817 1/20 0.46
ADRB1 P08588 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Phenol SCHEMBL27520072 0.97 CA12 (0.61) CA12CA1CA2GLACA3
Phenol SCHEMBL27499090 0.97 CA12 (0.61) CA12CA1CA2GLACA3
Phenol SCHEMBL27942638 0.94 CA12 (0.65) CA12CA1CA2GLACA3
Phenol SCHEMBL9396101 0.94 CA12 (0.65) CA12CA1CA2GLACA3
Phenol SCHEMBL5875310 0.92 CA12 (0.61) CA12CA1CA2GLACA3
Phenol SCHEMBL9237719 0.89 CA12 (0.58) CA12CA1CA2GLACA3
Phenol SCHEMBL27681918 0.88 CA12 (0.73) CA12CA1CA2GLACA3
Phenol SCHEMBL21753960 0.85 CA12 (0.69) CA12CA1CA2GLACA3
Phenol SCHEMBL27965678 0.85 CA12 (0.69) CA12CA1CA2GLACA3
Phenol SCHEMBL8375278 0.85 CA12 (0.69) CA12CA1CA2GLACA3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104203944-A Multi-fluorescent substance containing novel coumarin derivative and LED light source micro-fluorescence quantitative biosensor for diagnosis using same ACCOBIOTECH SDN BHD 2014-12-10 CN disclosed
CN-1046094-C Pharmaceutical composition of the type which undergoes liquid-gel phase transition LABORATORIRES MERCK SHARP & DO (FR) 1999-11-03 CN disclosed
CN-1181703-A Controlled release of mydriatic and miotic agents in the anterior chamber of the eye M A GALIN (US) 1998-05-13 CN disclosed
EP-0427572-B1 Process for preparing N-alkylaminophenols and N,N-dialkylaminophenols SUMITOMO CHEMICAL CO (JP) 1994-04-27 EP disclosed
EP-0411817-B1 Process for preparing N-alkyl-substituted aminophenols SUMITOMO CHEMICAL CO (JP) 1994-04-06 EP disclosed
US-5276193-A Reductive alkylation, addition of carboxylic acid to prevent by-product formation SUMITOMO CHEMICAL CO., LTD. (JP) 1994-01-04 US disclosed
US-5202485-A Catalytic reductive alkylation of aminophenol using aldehyde or ketone SUMITOMO CHEMICAL CO., LTD. (JP) 1993-04-13 US disclosed
EP-0411817-A2 Process for preparing N-alkyl-substituted aminophenols SUMITOMO CHEMICAL COMPANY, LIMITED (JP) 1991-02-06 EP disclosed
CN-86106637-A Pharmaceutical composition capable of liquid-gel phase transition 1987-04-08 CN disclosed